| CTRI Number |
CTRI/2024/06/069669 [Registered on: 28/06/2024] Trial Registered Prospectively |
| Last Modified On: |
27/06/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Sedation with two different drugs and postoperative recovery in patients undergoing Endoscopic Retrograde Cholangiopancreatography |
|
Scientific Title of Study
|
Comparison between Dexmedetomidine and Magnesium sulphate as adjuvants to propofol for postoperative recovery in patients undergoing Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care A Randomised Comparative Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Geeta Singariya |
| Designation |
Senior Professor |
| Affiliation |
Dr S N medical collage Jodhpur |
| Address |
123 Vaishali avenue Jhanwar road Jodhpur Main OT Complex First floor Department of Anaesthesia MDM Hospital Dr S N medical collage Jodhpur RAJASTHAN 342001 Jodhpur RAJASTHAN 342008 India |
| Phone |
9414803554 |
| Fax |
|
| Email |
geetamanojkamal@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Alisha P V |
| Designation |
Junior Resident |
| Affiliation |
Dr S N medical collage Jodhpur |
| Address |
Main OT Department of Anaesthesia First Floor MDM hospital Dr S N medical collage Jodhpur Rajasthan 342001 Main OT Department of Anaesthesia First Floor MDM hospital Dr S N medical collage Jodhpur Rajasthan 342001 Jodhpur RAJASTHAN 342001 India |
| Phone |
7356377155 |
| Fax |
|
| Email |
alishapv96@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Geeta Singariya |
| Designation |
Senior Professor |
| Affiliation |
Dr S N medical collage Jodhpur |
| Address |
MDM hospital Dr S N Medical Collage Jodhpur Main OT Complex First floor Department of Anaesthesia MDM Hospital Dr S N medical collage Jodhpur RAJASTHAN 342001
Jodhpur RAJASTHAN DrGeeta Singariya India |
| Phone |
9414803554 |
| Fax |
|
| Email |
geetamanojkamal@gmail.com |
|
|
Source of Monetary or Material Support
|
| MDM Hospital Dr S N Medical Collage Jodhpur RAJASTHAN 342001 |
|
|
Primary Sponsor
|
| Name |
M D M Hospital Dr S N Medical College Jodhpur |
| Address |
First floor Main operation theater MDM Hospital Dr S N Medical College Shastri Nagar Jodhpur Rajasthan 342001 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrGeeta Singariya |
MDM hospital, Dr S N Medical collage, Jodhpur |
OT Complex Third floor Department of anesthesia M D M Hospital Dr S N Medical College Shastri Nagar Dr S N medical collage, Jodhpur Jodhpur RAJASTHAN
Jodhpur RAJASTHAN |
9414803554
geetamanojkamal@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Dr S N Medical College Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Dexmedetomidine |
Dexmedetomidine 1 mcg/kg IV as a bolus in 100 ml of 0.9% normal saline over 10 minutes, followed by propofol loading dose of 0.25mg/kg and 10 mg supplementary dose till RSS 4 |
| Comparator Agent |
Magnesium sulphate |
Magnesium sulphate 50 mg/kg IV as a bolus in 100 ml of 0.9% normal saline over 10 minutes, followed by propofol loading dose of 0.25mg/kg and 10 mg supplementary dose till RSS 4 |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
The adult patients, aged 18 to 60 years of both genders, belong to ASA PS I and II, undergoing ERCP under Monitored anaesthesia care. |
|
| ExclusionCriteria |
| Details |
1. Patient refusal
2. History of any allergy to related medications
3. Patients receiving magnesium sulphate supplementation
4. Patients with psychiatric history, myopathy, neurological disease and other comorbidities.
5. Pregnant woman
6. Procedure time greater than 60 minutes
|
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To compare quality of postoperative recovery from anesthesia in terms of modified Aldrete score in patients undergoing endoscopic retrograde cholangiopancreatography under monitored anesthesia care with dexmedetomidine and magnesium sulphate as adjuvants to propofol |
120 mins |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Hemodynamic monitoring
Total propofol consumption
Ramsay sedation score
Postprocedural VAS score
Complications
Surgeon satisfaction
Patient satisfaction using Likert score
|
24 Hours |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
08/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [geetamanojkamal@gmail.com].
- For how long will this data be available start date provided 01-07-2025 and end date provided 01-07-2030?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
This study will be conducted in the Department of Anaesthesiology in DR S N
Medical College and the associated group of hospitals. To
ensure inclusion in the study, each patient will be subjected to a detailed
pre-anaesthetic evaluation based on detailed history from
patients/attenders, thorough physical examination, and pre-anaesthetic
airway assessment. Baseline investigations will be done in all the patients to
rule out any abnormalities. The purpose and detailed procedure will be
explained to the patients. Written informed consent will be taken from all the
patients about the procedure. All patients will be kept nil by mouth as per
standard guidelines before the scheduled time of surgery. The patient’s NBM status will be confirmed
before the scheduled time of surgery. After arrival to the operating room,
routine parameters like heart rate, ECG, pulse oximetry and non-invasive blood
pressure will be recorded (for the baseline values). The intravenous line will be
secured using an 18/20 G IV cannula and Inj. Ringer Lactate will be started
slowly.
The randomization will be done on a computer-generated
random number chart using block randomization (1:1) and allocation concealment
will be done by an opaque, sealed envelope method opened during pre-anesthetic
checkup. All patients will be randomly allocated into two groups, Group D (dexmedetomidine and
propofol) and Group M (magnesium sulphate and propofol). |